The Daily Brief for Benefits Professionals
BenefitsWire
Health & Welfare Plans
November 3, 2026
— § —
11 items · ~3 min read
In this issue
Regulatory Action and Guidance (5) · General Benefits (6)
Regulatory Action and Guidance
5 items“On October 30, 2026, HHS finalized a rule amending its regulations implementing Section 504 of the Rehabilitation Act. The rule clarifies that the statutory exclusion for “gender identity disorders not resulting from physical impairments” includes gender dysphoria not resulting from a physical impairment. The rule amends HHS’s existing Section 504 regulations and applies to recipients of HHS financial assistance, such as grants, premium tax credits, Medicare, or Medicaid. It is scheduled for publication in the Federal Register on November 3, 2026, and will take effect 60 days after publication.” MORE >>
Source: Groom Law Group
The FDA classified over-the-counter sleep apnea risk assessment devices into class II, establishing special controls to ensure safety and effectiveness while improving patient access to innovative devices. MORE >>
Source: Federal Register
“On January 1, 2027, amendments to Washington’s Healthy Starts Act take effect. The newly amended law requires employers, for the first time, to pay employees at their regular compensation rate, for up to two years after a child’s birth, for time spent expressing breast milk at work and for time spent traveling to a location the employer and employee identify for that purpose. Employers cannot require employees to use paid leave for this time, and the breaks are in addition to meal and rest periods.” MORE >>
Source: Arnold & Porter
“Date: Large employers that pay for their workers’ health care directly will soon be able to see how much their pharmacy benefit managers make on every prescription, under a final rule the U.” MORE >>
Source: National Law Review
HHS announced an enforcement discretion policy for compounding with certain peptide bulk drug substances under section 503A while the official list is developed, providing temporary guidance for pharmacies. MORE >>
Source: Federal Register
General Benefits
6 items“If you sponsor or administer an employee benefit plan, two recent federal court decisions should be on your radar....” MORE >>
Source: Falcon Rappaport & Berkman LLP
“12.04.2025 Washington, DC Kevin Lowell will speak at the U.S. Department of Justice (DOJ) Annual Healthcare Fraud Investigations Training on December 4, 2025. Lowell will present "Autism Therapy Fraud: Early Detection, Coordination, and Enforcement.” MORE >>
Source: Miller & Chevalier
“As employers face another year of significant health plan cost increases, many are taking a closer look at self-funding as a potential way to gain greater control over their health plan costs. But the financial analysis should not be the only item on the to-do list. Moving from a fully insured health plan to a self-funded arrangement can also change an employer’s responsibilities under the Health Insurance Portability and Accountability Act (HIPAA). A group health plan is a covered entity under HIPAA. With a fully insured plan, however, the insurance carrier frequently handles many of the functions involving protected health information (PHI), which can significantly limit the HIPAA complian” MORE >>
Source: Bricker Graydon
“HR leaders spend a great deal of time evaluating the employee experience. They compare health plans, review leave programs, and invest in benefits that help employees feel supported.” MORE >>
Source: Employee Benefit News
“Specialty pharmacy data underpins some of the most valuable commercial channel decisions that life sciences companies make: payer contracting, field force deployment, hub investment, and pull-through targeting. The stakes are high. Specialty drugs flow through an increasingly large and fragmented dispensing channel. In 2025, U.S. pharmacies dispensed an estimated $293.4 billion in specialty drugs.1 Yet the channel generating this data has become harder to observe.” MORE >>
Source: Milliman
“Clinical AI tools are being widely adopted to support clinical decision-making and reduce administrative burdens that often result in clinician burnout. However, concerns about who is liable when AI tools make mistakes are top of mind for physicians. An AMA survey released earlier this year shows that a third of physicians cited “clear liability frameworks" as the primary driver of AI adoption.” MORE >>
Source: Healthcare Dive